These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 7912392)
21. Unexpected white matter changes in an early treated PKU case and improvement after dietary treatment. Battistini S; De Stefano N; Parlanti S; Federico A Funct Neurol; 1991; 6(2):177-80. PubMed ID: 1916459 [TBL] [Abstract][Full Text] [Related]
22. White matter pathology in phenylketonuria. Anderson PJ; Leuzzi V Mol Genet Metab; 2010; 99 Suppl 1():S3-9. PubMed ID: 20123467 [TBL] [Abstract][Full Text] [Related]
23. [Neurological, neuropsychological, and ophthalmological evolution after one year of docosahexaenoic acid supplementation in phenylketonuric patients]. Gutiérrez-Mata AP; Vilaseca MA; Capdevila-Cirera A; Vidal-Oller M; Alonso-Colmenero I; Colomé R; López-Sala A; Lambruschini-Ferri N; Gutiérrez A; Gassió R; Artuch R; Campistol J Rev Neurol; 2012 Aug; 55(4):200-6. PubMed ID: 22829083 [TBL] [Abstract][Full Text] [Related]
24. The pathogenesis of the white matter abnormalities in phenylketonuria. A multimodal 3.0 tesla MRI and magnetic resonance spectroscopy (1H MRS) study. Leuzzi V; Tosetti M; Montanaro D; Carducci C; Artiola C; Carducci C; Antonozzi I; Burroni M; Carnevale F; Chiarotti F; Popolizio T; Giannatempo GM; D'Alesio V; Scarabino T J Inherit Metab Dis; 2007 Apr; 30(2):209-16. PubMed ID: 17245558 [TBL] [Abstract][Full Text] [Related]
25. [Brain white matter lesions of children with phenylketonuria before and after treatment]. Wang ZX; Zhou ZS; Yu WM Zhongguo Dang Dai Er Ke Za Zhi; 2006 Feb; 8(1):13-6. PubMed ID: 16522231 [TBL] [Abstract][Full Text] [Related]
26. Cranial MRI in PKU: evaluation of a critical threshold for blood phenylalanine. Ullrich K; Weglage J; Schuierer G; Fünders B; Pietsch M; Koch HG; Hahn-Ullrich H Neuropediatrics; 1994 Oct; 25(5):278-9. PubMed ID: 7885543 [TBL] [Abstract][Full Text] [Related]
27. True Restriction in Diffusion-Weighted Imaging in a Mistreated Patient With Phenylketonuria. Palaiodimou L; Zompola C; Lachanis S; Mylona V; Theodorou A; Papagiannopoulou G; Kotsali-Peteinelli V; Foska A; Kasti A; Skouma A; Tsivgoulis G Neurologist; 2020 Dec; 26(1):20-21. PubMed ID: 33394907 [TBL] [Abstract][Full Text] [Related]
28. Adult phenylketonuria presenting with subacute severe neurologic symptoms. Seki M; Takizawa T; Suzuki S; Shimizu T; Shibata H; Ishii T; Hasegawa T; Suzuki N J Clin Neurosci; 2015 Aug; 22(8):1361-3. PubMed ID: 25913748 [TBL] [Abstract][Full Text] [Related]
32. Event-related potential correlates of selective processing in early- and continuously-treated children with phenylketonuria: effects of concurrent phenylalanine level and dietary control. de Sonneville LM; Huijbregts SC; van Spronsen FJ; Verkerk PH; Sergeant JA; Licht R Mol Genet Metab; 2010; 99 Suppl 1():S10-7. PubMed ID: 20123462 [TBL] [Abstract][Full Text] [Related]
33. Subclinical visual impairment in phenylketonuria. A neurophysiological study (VEP-P) with clinical, biochemical, and neuroradiological (MRI) correlations. Leuzzi V; Rinalduzzi S; Chiarotti F; Garzia P; Trasimeni G; Accornero N J Inherit Metab Dis; 1998 Jun; 21(4):351-64. PubMed ID: 9700592 [TBL] [Abstract][Full Text] [Related]
34. Morphometric analysis of gray matter integrity in individuals with early-treated phenylketonuria. Christ SE; Price MH; Bodner KE; Saville C; Moffitt AJ; Peck D Mol Genet Metab; 2016 May; 118(1):3-8. PubMed ID: 26947918 [TBL] [Abstract][Full Text] [Related]
35. Progression of cerebral white matter abnormalities in early treated patients with phenylketonuria during adolescence. Weglage J; Bick U; Schuierer G; Pietsch M; Sprinz A; Zass R; Ullrich K Neuropediatrics; 1997 Aug; 28(4):239-40. PubMed ID: 9309716 [TBL] [Abstract][Full Text] [Related]
37. Brain MRI changes in phenylketonuria. Associations with dietary status. Thompson AJ; Tillotson S; Smith I; Kendall B; Moore SG; Brenton DP Brain; 1993 Aug; 116 ( Pt 4)():811-21. PubMed ID: 8353710 [TBL] [Abstract][Full Text] [Related]
38. Neurophysiological, psychological, and nutritional investigations during discontinuation of the phenylalanine-restricted diet in children with classic phenylketonuria. Pueschel SM; Fogelson-Doyle L; Kammerer B; Matsumiya Y J Ment Defic Res; 1983 Mar; 27 (Pt 1)():61-7. PubMed ID: 6615595 [TBL] [Abstract][Full Text] [Related]
39. Complete reversal of moderate/severe brain MRI abnormalities in a patient with classical phenylketonuria. Walter JH; White F; Wraith JE; Jenkins JP; Wilson BP J Inherit Metab Dis; 1997 Jul; 20(3):367-9. PubMed ID: 9266357 [No Abstract] [Full Text] [Related]